- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Nasdaq
Wall Street JournalEN
C
CLBT
Cellebrite Di Ltd
13.16
-0.62-4.50%After Hours: 13.50 +0.34 +2.58%18:15 02/20 EST
OPEN/PREV CLOSE13.70/13.78
TODAY RANGE13.14-14.00
VOL1.87M
MARKET CAP3.22B
52 WEEK RANGE13.10-20.86
AVG VOL (3M)1.43M
% TURNOVER0.77%
TURNOVER--
P/E (TTM)41.99
% RANGE6.24%
EPS(TTM)0.3134
P/E(FORWARD)37.60
P/B6.64
BVPS1.981
DIVIDEND--
P/S6.76
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.66B
SHARES OUTSTANDING244.47M
NEXT EARNINGS05/12-05/18
FREE FLOAT126.44M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
NASDAQ·3d ago
CLBT December 18th Options Begin Trading
TipRanks·6d ago
Cellebrite Earnings Call Highlights Growth, Cash Strength
Simply Wall St·02/14 14:23
Did Cellebrite’s 2026 Guidance and Forensics Acquisitions Just Recast CLBT’s SaaS Investment Narrative?
Simply Wall St·02/13 08:30
A Look At Cellebrite DI (CLBT) Valuation After 2026 Guidance And Forensics Acquisitions
NASDAQ·02/12 17:08
Relative Strength Alert For Cellebrite DI
TipRanks·02/12 13:41
Cellebrite price target lowered to $23 from $25 at TD Cowen
TipRanks·02/12 13:40
Cellebrite price target lowered to $21 from $23 at Lake Street
Dow Jones·02/12 13:12
Cellebrite DI Is Maintained at Buy by Needham
Dow Jones·02/12 13:12
Cellebrite DI Price Target Cut to $18.00/Share From $24.00 by Needham
Benzinga·02/12 13:02
Needham Maintains Buy on Cellebrite DI, Lowers Price Target to $18
Seeking Alpha·02/12 06:55
Cellebrite outlines 18%-19% ARR growth target for 2026 amid SaaS, cloud, and AI expansion
Simply Wall St·02/12 02:35
Cellebrite (CLBT) Profitability Run Tests Bull Narratives As High P/E Stays In Focus
Same Industry
Name/Symbol
Change%
Price